Related Experiment Video
Updated: Mar 14, 2026
14:19
Fetal Echocardiography and Pulsed-wave Doppler Ultrasound in a Rabbit Model of Intrauterine Growth Restriction
Published on: June 29, 2013
28.8K
Early onset fetal growth restriction.
Aamod Nawathe1, Christoph Lees1
1Queen Charlotte's and Chelsea Hospital, London, W120HS, UK.
Best Practice & Research. Clinical Obstetrics & Gynaecology
|October 4, 2016
Summary
Managing early onset fetal growth restriction (FGR) is complex due to varying causes and outcomes. This review focuses on diagnosis, monitoring, and optimal delivery timing for early FGR, incorporating recent research.
Area of Science:
- Obstetrics and Gynecology
- Perinatal Medicine
- Fetal Medicine
Background:
- Fetal growth restriction (FGR) presents clinical challenges globally.
- Early and late FGR have distinct etiopathogenesis, severity, and outcomes.
- Clinical management is complicated by physician and patient anxiety.
Purpose of the Study:
- To review diagnostic and monitoring strategies for early onset FGR.
- To emphasize optimal timing of delivery for early onset FGR.
- To incorporate recent research advances into management guidelines.
Main Methods:
- Literature review of diagnostic and monitoring techniques for early onset FGR.
- Analysis of recent research on fetal severity progression and outcomes.
- Synthesis of evidence regarding optimal timing of delivery.
Main Results:
- Early onset FGR requires tailored diagnostic and monitoring approaches.
- Understanding disease progression is crucial for intervention.
- Evidence supports specific timing for delivery based on fetal well-being.
Conclusions:
- Optimal management of early onset FGR involves accurate diagnosis and vigilant monitoring.
- Timely delivery, guided by fetal status, improves outcomes.
- Continued research is vital for refining early FGR management strategies.
Related Concept Videos
01:07Teratogenicity
4.4K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.4K
01:20Inborn Errors of Metabolism
985
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
985